The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(4-benzylpiperazin-1-yl)-N-(4-sulfamoylcyclohexa-2,5-dienyl)propanamide ID: ALA1077151
PubChem CID: 46881373
Max Phase: Preclinical
Molecular Formula: C20H28N4O3S
Molecular Weight: 404.54
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: NS(=O)(=O)C1C=CC(NC(=O)CCN2CCN(Cc3ccccc3)CC2)C=C1
Standard InChI: InChI=1S/C20H28N4O3S/c21-28(26,27)19-8-6-18(7-9-19)22-20(25)10-11-23-12-14-24(15-13-23)16-17-4-2-1-3-5-17/h1-9,18-19H,10-16H2,(H,22,25)(H2,21,26,27)
Standard InChI Key: KCEXHFMNAPSTBL-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
18.5167 -5.1333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3417 -5.1333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7519 -4.4228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3417 -3.7077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5167 -3.7077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1019 -4.4228 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5769 -4.4240 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
20.9884 -5.1390 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.3583 -3.6208 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.3708 -4.2042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.2769 -4.4240 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.8634 -3.7101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0384 -3.7112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2749 -2.9950 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.6249 -2.9973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7999 -2.9985 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3929 -2.2830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5715 -2.2822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1562 -2.9954 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.5684 -3.7111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3961 -3.7136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3312 -2.9934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9170 -3.7069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0936 -3.7018 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6795 -4.4145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0903 -5.1309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9196 -5.1303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3300 -4.4170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12 14 2 0
3 7 1 0
13 15 1 0
1 2 2 0
15 16 1 0
16 17 1 0
7 8 1 0
1 6 1 0
7 9 2 0
2 3 1 0
7 10 2 0
16 21 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
3 4 1 0
19 22 1 0
6 11 1 0
22 23 1 0
4 5 2 0
23 24 2 0
11 12 1 0
24 25 1 0
5 6 1 0
25 26 2 0
12 13 1 0
26 27 1 0
27 28 2 0
28 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 404.54Molecular Weight (Monoisotopic): 404.1882AlogP: 0.46#Rotatable Bonds: 7Polar Surface Area: 95.74Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.44CX Basic pKa: 8.12CX LogP: 0.49CX LogD: -0.30Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.64Np Likeness Score: -1.12
References 1. Oltulu O, Yaşar MM, Eroğlu E.. (2009) A QSAR study on relationship between structure of sulfonamides and their carbonic anhydrase inhibitory activity using the eigenvalue (EVA) method., 44 (9): [PMID:19303173 ] [10.1016/j.ejmech.2009.02.016 ]